Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 208.50
-3.50 (-1.65%)
Mar 26, 2026, 1:30 PM CST
Lotus Pharmaceutical Revenue
In the year 2025, Lotus Pharmaceutical had annual revenue of 20.51B TWD with 10.36% growth. Lotus Pharmaceutical had revenue of 6.26B in the quarter ending December 31, 2025, with 42.03% growth.
Revenue
20.51B
Revenue Growth
+10.36%
P/S Ratio
2.67
Revenue / Employee
18.66M
Employees
1,099
Market Cap
54.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.51B | 1.93B | 10.36% |
| Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
| Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
| Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
| Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.16B |